Dr. Silvia Corvera's lab focuses on understanding how human adipose (fat) tissue regulates metabolism and energy balance, especially in the context of diseases like Type 2 Diabetes. By studying the activities of different types of human fat cells in laboratory models, they aim to uncover the mechanisms that control fat storage and energy expenditure, which are crucial for preventing metabolic disorders. Their groundbreaking research includes techniques to develop functional human fat in mice, allowing for innovative studies on fat cell behavior and the effects of specific genes on metabolism.

Dr. Susan L. Swain's lab at the University of Massachusetts Medical School focuses on understanding how aging affects the immune response to influenza. The research particularly examines a unique population of B cells that may help protect older adults from flu infections. By studying how these cells respond to different types of vaccines, the lab aims to improve vaccine efficacy for the elderly, who are particularly vulnerable to flu and other viruses like COVID-19.

Dr. Gowthaman Uthaman's lab at the University of Massachusetts Medical School focuses on understanding how specific immune cells contribute to allergenic responses in the body. The research particularly investigates a novel type of T helper cell, called Tfh13 cells, which are vital in producing IgE antibodies responsible for dangerous allergic reactions. By studying these cells, the lab aims to discover new ways to prevent or treat severe allergies and anaphylaxis.

Eduardo Martin Torres's lab investigates how an abnormal number of chromosomes affects cell function, particularly in Down syndrome. Their research seeks to understand the mechanisms that link aneuploidy (having an incorrect number of chromosomes) to developmental and aging-related issues in patients. The team focuses on cell structure, especially the nuclear membrane, to discover pathways that might help suppress negative effects associated with Down syndrome and promote health in affected individuals.

Eric H Baehrecke's lab at the University of Massachusetts Medical School studies the process of autophagy, which is how cells recycle and dispose of cellular waste. The research focuses on understanding how autophagy is regulated during the development of the fruit fly (Drosophila), providing insights that could help us understand similar processes in humans and how they are linked to diseases like cancer and neurodegeneration. By studying autophagy in specific cell types in the intestines, the lab aims to uncover how different cellular components are selected for degradation, which could lead to new therapeutic strategies for human health.

Dr. Michael Czech's lab focuses on understanding how certain fat cells, called beige adipocytes, can improve metabolic health in conditions like obesity and diabetes. They use advanced CRISPR technology to convert regular fat cells into beige adipocytes, which can help in weight loss and improve body metabolism. The lab's research aims to discover the underlying mechanisms that allow these fat cells to help the body utilize energy better and combat fat accumulation in the liver.

Dr. Jennifer A Benanti's lab studies how cells grow and divide, focusing specifically on the cell cycle, which is crucial for normal development and cancer prevention. By investigating molecular mechanisms, particularly the role of phosphorylation, her research aims to uncover how cells respond to stress and how mutations can contribute to diseases like cancer. Overall, her work seeks to find new strategies for controlling cellular proliferation and improving therapeutic approaches in oncology.

Dr. Roger J. Davis's lab at the University of Massachusetts Medical School focuses on understanding how obesity impacts metabolic health. The research specifically investigates the role of JNK signaling pathways in fat tissue, aiming to uncover how these pathways contribute to inflammation and insulin resistance associated with obesity. By identifying molecular mechanisms involved in these processes, the lab seeks to inform new treatment strategies for metabolic syndrome and type 2 diabetes.

Dr. Merav Socolovsky's lab focuses on understanding the process of red blood cell formation, called erythropoiesis. The lab investigates how specific signaling pathways, specifically those involving EpoR and Stat5, regulate protein synthesis and ribosome production during the critical stages of erythroid cell development. This research aims to uncover the connections between cell cycle duration, cell growth, and the quality of DNA replication, which could have important implications for both developmental biology and diseases like anemia and cancer.

Dr. Thomas Fazzio's lab focuses on understanding the genetic and epigenetic mechanisms that drive early mammalian development. They utilize cutting-edge techniques to identify and characterize genetic variants within regulatory elements that influence gene expression. The lab's work aims to clarify how these genetic changes affect cell fate decisions, ultimately contributing to our understanding of developmental disorders and improving regenerative medicine strategies.

The lab led by Dr. Kenneth L Rock studies how the immune system responds to cell injury and death, focusing particularly on histones - molecules released when cells die. By identifying novel receptors that detect these histones, the lab aims to understand their role in triggering inflammation and how this relates to various diseases such as strokes and infections. Their findings could help develop new treatments to prevent or treat related health issues.

Dr. Jeremy Luban's lab at the University of Massachusetts Medical School focuses on understanding how the HUSH complex contributes to HIV-1 latency. The research aims to pinpoint the mechanisms by which the HUSH complex silences HIV-1 proviruses in immune cells, which is a key factor in why current treatments don't lead to a cure. By investigating this complex, the lab hopes to discover new strategies for eradicating the virus from the body, which remains dormant in long-lived memory T cells despite antiretroviral therapy.

Dr. Jiann-Jyh Lai's lab at the University of Massachusetts Medical School focuses on understanding how the immune system detects cell injury and initiates inflammatory responses. Their research specifically investigates novel receptors and ligands that are involved in this process, which can impact various diseases. By using both human and mouse models, the lab aims to uncover new mechanisms that could lead to innovative treatments for conditions like stroke, heart attacks, and cancer.

Dr. Joonsoo Kang's lab explores how cholesterol metabolites affect the immune system, particularly in the skin of children. They study a specific type of immune cell called type 3 lymphocytes, which are important for skin health and barrier function. By analyzing how these cells develop and respond to dietary influences, the lab aims to uncover links between nutrition, immune response, and common skin diseases such as psoriasis and eczema.

Dr. Nathan D Lawson's lab at the University of Massachusetts Medical School focuses on understanding the development and function of blood vessels in the body. They study the role that specific cell types, such as pericytes and the gene Rasa1, play in vascular health, particularly during embryonic development. Using zebrafish as a model organism, the lab identifies the genetic and molecular factors that contribute to vascular and lymphatic anomalies, which can lead to serious health conditions.

Dr. Brian C. Lewis's lab at the University of Massachusetts Medical School focuses on understanding and potentially treating pancreatic cancer, a leading cause of cancer deaths. The lab studies how specific signaling pathways, particularly the MTOR pathway, contribute to tumor growth and survival. They utilize advanced mouse models and human cancer cell lines to investigate the effects of inhibiting this pathway, aiming to find new therapeutic strategies for effective treatment.

Dr. Jason K. Kim's lab focuses on understanding how insulin resistance and inflammation in the liver are linked to Alzheimer's disease. They research the roles of immune cells and inflammatory signals on brain health, exploring how these factors influence cognitive decline in aging individuals. Their findings aim to uncover potential new treatments for Alzheimer's and related neurodegenerative diseases.

Dr. Cole Haynes' lab focuses on understanding how cells generate and maintain mitochondrial networks, especially as they relate to aging and age-related diseases like Alzheimer's and Parkinson's. By studying a specific transcription factor, ATFS-1, the lab aims to uncover the mechanisms that control mitochondrial function and biogenesis during development and throughout an organism's life. This research could help develop strategies for improving mitochondrial health in aging populations.

Dr. Craig L Peterson's lab at the University of Massachusetts Medical School focuses on understanding how the structure of chromosomes influences important cellular processes like gene expression, DNA replication, and repair. The lab investigates chromatin remodeling machines that play a critical role in maintaining genome stability and preventing diseases, including cancer. By using various experimental techniques, the lab aims to uncover the mechanisms behind chromatin dynamics and their implications for cellular function.

Dr. Arthur M. Mercurio's lab focuses on understanding and overcoming resistance to radiation therapy in triple negative breast cancer (TNBC). The lab aims to explore how the interaction between vascular endothelial growth factor (VEGF) and its receptor, neuropilin-2 (NRP2), contributes to radiation resistance. By leveraging patient-derived models and organoids, the team seeks to discover novel therapies that enhance the effectiveness of radiotherapy in treating aggressive forms of breast cancer.